Advanced search
Publication Cover
Expert Review of Hematology Volume 6, 2013 - Issue 3
Submit an article Journal homepage
108
Views
15
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Higher-risk myelodysplastic syndromes with del(5q): is sequential azacitidine–lenalidomide combination the way to go?

Amer M Zeidan Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, The Johns Hopkins University, Baltimore, MD, USA. [email protected]; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, The Johns Hopkins University, Baltimore, MD, USA. [email protected]
,
Steven D Gore Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, The Johns Hopkins University, Baltimore, MD, USA. [email protected]; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, The Johns Hopkins University, Baltimore, MD, USA. [email protected]
&
Rami S Komrokji Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA
Pages 251-254 | Published online: 10 Jan 2014

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Russell Lewis, Jan Philipp Bewersdorf & Amer M Zeidan. (2021) Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options. Cancer Management and Research 13, pages 645-657.
Read now
Amer M. Zeidan, Maximilian Stahl & Rami Komrokji. (2016) Emerging biological therapies for the treatment of myelodysplastic syndromes. Expert Opinion on Emerging Drugs 21:3, pages 283-300.
Read now
Abdallah Abou Zahr, Ehab Saad Aldin, Rami S Komrokji & Amer M Zeidan. (2015) Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes. Journal of Blood Medicine 6, pages 1-16.
Read now
Abdallah Abou Zahr, Ehab Saad Aldin, Lisa Barbarotta, Nikolai Podoltsev & Amer M Zeidan. (2015) The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes. Expert Review of Anticancer Therapy 15:9, pages 1019-1036.
Read now
Chunli Dan, Jianxiang Chi & Li Wang. (2015) Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy. Annals of Medicine 47:3, pages 209-217.
Read now
Bishoy Faltas, Amer Zeidan & Usama Gergis. (2013) Myelodysplastic syndromes: toward a risk-adapted treatment approach. Expert Review of Hematology 6:5, pages 611-624.
Read now

Articles from other publishers (9)

Amer M. Zeidan, Rory M. Shallis, Rong Wang, Amy Davidoff & Xiaomei Ma. (2019) Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it. Blood Reviews 34, pages 1-15.
Crossref
Ota Fuchs. (2019) Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs. Cardiovascular & Hematological Disorders-Drug Targets 19:1, pages 51-78.
Crossref
Amer M. Zeidan, Maximilian Stahl, Mikkael A. Sekeres, David P. Steensma, Rami S. Komrokji & Steven D. Gore. (2017) A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials. Cancer 123:19, pages 3662-3672.
Crossref
Maximilian Stahl & Amer M. Zeidan. (2017) Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications. Cancer 123:10, pages 1703-1713.
Crossref
Amer M. Zeidan, B. Douglas Smith, Hetty E. Carraway, Ivana Gojo, Amy DeZern & Steven D. Gore. (2017) A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia. British Journal of Haematology 176:2, pages 241-247.
Crossref
Suxia Geng, Han Yao, Jianyu Weng, Jiaqi Tong, Xin Huang, Ping Wu, Chengxin Deng, Minming Li, Zesheng Lu & Xin Du. (2016) Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cells. Leukemia Research 44, pages 17-24.
Crossref
Amer M. Zeidan, Ju-Whei Lee, Thomas Prebet, Peter Greenberg, Zhuoxin Sun, Mark Juckett, Mitchell R. Smith, Elisabeth Paietta, Janice Gabrilove, Harry P. Erba, Rhett P. Katterling, Martin S. Tallman & Steven D. Gore. (2014) Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS. British Journal of Haematology 167:1, pages 62-68.
Crossref
Amer M. Zeidan & Rami S. Komrokji. (2013) There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes. Current Hematologic Malignancy Reports 8:4, pages 351-360.
Crossref
Amer M. Zeidan, Yuliya Linhares & Steven D. Gore. (2013) Current therapy of myelodysplastic syndromes. Blood Reviews 27:5, pages 243-259.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.